Literature DB >> 25552370

Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.

Srikanth Manam1, Joshua D Thomas1, Weidang Li1, Allison Maladore1, Justin H Schripsema2, Kyle H Ramsey2, Ashlesh K Murthy1.   

Abstract

BACKGROUND: We demonstrated previously that tumor necrosis factor α (TNF-α)-producing Chlamydia-specific CD8(+) T cells cause oviduct pathological sequelae.
METHODS: In the current study, we used wild-type C57BL/6J (WT) mice with a deficiency in genes encoding TNF receptor superfamily member 1a (TNFR1; TNFR1 knockout [KO] mice), TNF receptor superfamily member 1b (TNFR2; TNFR2 KO mice), and both TNFR1 and TNFR2 (TNFR1/2 double KO [DKO] mice) and mix-match adoptive transfers of CD8(+) T cells to study chlamydial pathogenesis.
RESULTS: TNFR1 KO, TNFR2 KO, and TNFR1/2 DKO mice displayed comparable clearance of primary or secondary genital Chlamydia muridarum infection but significantly reduced oviduct pathology, compared with WT animals. The Chlamydia-specific total cellular cytokine response in splenic and draining lymph nodes and the antibody response in serum were comparable between the WT and KO animals. However, CD8(+) T cells from TNFR2 KO mice displayed significantly reduced activation (CD11a expression and cytokine production), compared with TNFR1 KO or WT animals. Repletion of TNFR2 KO mice with WT CD8(+) T cells but not with TNFR2 KO CD8(+) T cells and repletion of TNFR1 KO mice with either WT or TNFR1 KO CD8(+) T cells restored oviduct pathology to WT levels in both KO groups.
CONCLUSIONS: Collectively, these results demonstrate that TNFR2-bearing CD8(+) T cells and TNFR1-bearing non-CD8(+) T cells contribute significantly to oviduct pathology following genital chlamydial infection.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD8+ T cells; Chlamydia; TNF receptor 1; TNF receptor 2; genital infection; oviduct pathology

Mesh:

Substances:

Year:  2014        PMID: 25552370      PMCID: PMC4498131          DOI: 10.1093/infdis/jiu839

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Chlamydia.

Authors:  Robert Belland; David M Ojcius; Gerald I Byrne
Journal:  Nat Rev Microbiol       Date:  2004-07       Impact factor: 60.633

3.  TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.

Authors:  J J Peschon; D S Torrance; K L Stocking; M B Glaccum; C Otten; C R Willis; K Charrier; P J Morrissey; C B Ware; K M Mohler
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

Review 4.  Chlamydial salpingitis.

Authors:  L Weström; P A Mårdh
Journal:  Br Med Bull       Date:  1983-04       Impact factor: 4.291

5.  Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection.

Authors:  Muhammad T Imtiaz; Justin H Schripsema; Ira M Sigar; John N Kasimos; Kyle H Ramsey
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.

Authors:  H S Teh; A Seebaran; S J Teh
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

7.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

8.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

9.  Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.

Authors:  Yu Cong; Madhulika Jupelli; M Neal Guentzel; Guangming Zhong; Ashlesh K Murthy; Bernard P Arulanandam
Journal:  Vaccine       Date:  2007-02-23       Impact factor: 3.641

Review 10.  Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis.

Authors:  G Herbein; W A O'Brien
Journal:  Proc Soc Exp Biol Med       Date:  2000-03
View more
  16 in total

1.  MicroRNAs Modulate Pathogenesis Resulting from Chlamydial Infection in Mice.

Authors:  Laxmi Yeruva; Dakota L Pouncey; Michael R Eledge; Sudeepa Bhattacharya; Chunqiao Luo; Erin W Weatherford; David M Ojcius; Roger G Rank
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 2.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

3.  Caspase-11 Contributes to Oviduct Pathology during Genital Chlamydia Infection in Mice.

Authors:  Clare E Gyorke; Manoj K Tripathy; John Allen; Yugen Zhang; Angela Lovett; Stephanie A Montgomery; Uma M Nagarajan
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

4.  Cervical Cytokines Associated With Chlamydia trachomatis Susceptibility and Protection.

Authors:  Taylor B Poston; De'Ashia E Lee; Toni Darville; Wujuan Zhong; Li Dong; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Gregory D Sempowski; Xiaojing Zheng
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

5.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

6.  IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors:  Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-08-31       Impact factor: 2.700

7.  CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice.

Authors:  Mark T Zafiratos; Srikanth Manam; Kyle K Henderson; Kyle H Ramsey; Ashlesh K Murthy
Journal:  Pathog Dis       Date:  2015-07-27       Impact factor: 3.166

8.  Endocervical miRNA Expression Profiles in Women Positive for Chlamydia trachomatis with Clinical Signs and/or Symptoms Are Distinct from Those in Women Positive for Chlamydia trachomatis without Signs and Symptoms.

Authors:  Teresa A Batteiger; Nicole Spencer; Charity L Washam; Stephanie Byrum; Michael Eledge; Byron E Batteiger; Roger G Rank; Laxmi Yeruva
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 9.  Immunopathogenesis of Chlamydial Infections.

Authors:  Ashlesh K Murthy; Weidang Li; Kyle H Ramsey
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

10.  The Predominant CD4+ Th1 Cytokine Elicited to Chlamydia trachomatis Infection in Women Is Tumor Necrosis Factor Alpha and Not Interferon Gamma.

Authors:  Stephen J Jordan; Kanupriya Gupta; Brian M O Ogendi; Rakesh K Bakshi; Richa Kapil; Christen G Press; Steffanie Sabbaj; Jeannette Y Lee; William M Geisler
Journal:  Clin Vaccine Immunol       Date:  2017-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.